Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Neonatal Perinatal Med ; 11(3): 241-248, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30282376

RESUMEN

BACKGROUND: Contradictory evidence exists whether a prophylactic coagulation factor transfusion in the first hours of life (HOL) prevents intraventricular hemorrhage (IVH) in extreme preterm infants (EPI, <28 weeks gestation). We aimed to determine whether selective prophylactic solvent-detergent plasma and cryoprecipitate transfusion within 12 hours of life (SP-SDP/Cryoprecipitate-T) could prevent IVH in EPI. METHOD: This is a retrospective analysis, case-historical control, of prospectively collected data from a pre-existing electronic neonatal database at a Saudi tertiary neonatal intensive care unit. We compared the IVH rate in EPI born in the first 4 years (Jan 2010-Dec 2013) of the SP-SDP/Cryoprecipitate-T period with that of EPI born during the last 4 years (Jan 2006-Dec 2009) of the rescue SDP/Cryoprecipitate-T period. RESULTS: The IVH rate was lower in the SP compared to the rescue- SDP/Cryoprecipitate-T period (30.8% versus 51.2%, odds ratio 0.42, 95% confidence interval 0.21, 0.88, p = 0.02). This difference remained significant after controlling for six other IVH risk factors. CONCLUSIONS: Early SP-SDP/Cryoprecipitate-T may reduce the IVH rate in EPI. A large multicenter clinical trial is required for confirm the short and long-term benefit and risk of this intervention. Until then, early SP-SDP/Cryoprecipitate-T may be considered by an institution with a persistently high IVH rate.


Asunto(s)
Transfusión de Componentes Sanguíneos/métodos , Hemorragia Cerebral/prevención & control , Coagulantes/uso terapéutico , Factor VIII/uso terapéutico , Fibrinógeno/uso terapéutico , Enfermedades del Prematuro/terapia , Estudios de Casos y Controles , Detergentes/uso terapéutico , Femenino , Edad Gestacional , Humanos , Recien Nacido Extremadamente Prematuro , Recién Nacido , Enfermedades del Prematuro/fisiopatología , Unidades de Cuidado Intensivo Neonatal , Masculino , Estudios Retrospectivos , Factores de Riesgo , Solventes/uso terapéutico , Resultado del Tratamiento
2.
Hum Exp Toxicol ; 35(11): 1227-1239, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26818447

RESUMEN

The use of doxorubicin (DOX) as an antitumor therapeutic agent is limited due to its cardiotoxic effects. Metformin (Met) and sitagliptin (Sitg) are suggested to improve cardiac function. The present study aimed to determine the potential protective effects of Met and Sitg on DOX-induced cardiotoxicity. Rats were divided into six groups: groups I, II, and III received normal saline, Met, and Sitg, respectively. Groups IV, V, and VI received DOX only, Met + DOX, and Sitg + DOX, respectively. Heart tissue was used for biochemical assays which measured cardiac reduced glutathione (GSH), thiobarbituric acid reactive substances (TBARS), and tumor necrosis factor α (TNF-α). Serum creatinine kinase (CK) and lactate dehydrogenase (LDH) were also measured. The heart apex was prepared for histological (hematoxylin and eosin) and immunohistochemical examination. Intoxication of DOX was associated with a significant elevation in serum CK-MB and LDH, reduction in cardiac GSH, and increased TBARS and TNF-α compared to the controls. Administration of Met or Sitg to DOX-intoxicated rats suppressed serum CK-MB and LDH. Moreover, cardiac GSH was elevated with decreased TBARS and TNF-α. These results were confirmed by histological study. Met and Sitg caused inhibition of caspase 3 and upregulation of B-cell lymphoma 2 (Bcl-2) expression in DOX-intoxicated animals. Sitg was found to exert a significantly better protective effect compared to that of Met. It was concluded that Sitg might be more effective than Met in reducing myocardial injury in DOX-induced cardiotoxicity in rats.

3.
Forensic Sci Int Genet ; 11: 26-30, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24632058

RESUMEN

Recently, many researchers have focused on analysis of different X-chromosomal STRs as they bear the potential to efficiently complement the analysis of autosomal and Y-chromosomal STRs in solving special complex kinship deficiency cases. In the current study we examined a sample of 250 unrelated Egyptian males with the Investigator Argus X-12 kit (Qiagen GmbH, Hilden, Germany) which detects 12 X-STR markers distributed over the entire X-chromosome as four closely linked clusters. Microvariant off ladder alleles as well as null alleles have been detected in some loci. Furthermore, discordant results were observed between the Investigator Argus X-12 and the Mentype(®) Argus X-8 kits (Biotype AG, Dresden, Germany). New primers were designed for loci DXS10101, DXS10146 and DXS10148 to correct the allele drop outs observed in these loci with the Investigator Argus X-12 kit. Additionally, DNA sequence analysis revealed the polymorphisms responsible for the allele drop outs. Furthermore, six additional X-STRs (DXS10161, DXS10159, DXS10162, DXS10163, DXS10164 and DXS10165) located in the centromere region at Xp11.21-Xq11.1 were examined in a single multiplex reaction. Allele and haplotype frequencies as well as different forensic statistical parameters of the 18 X-STR loci tested indicated that they are highly informative in different forensic applications in the Egyptian population. However, some modifications still need to be performed on the Investigator Argus X-12 kit before its use in forensic casework is validated.


Asunto(s)
Centrómero , Cromosomas Humanos X , Genética de Población , Repeticiones de Microsatélite/genética , Polimorfismo Genético , Secuencia de Bases , Cartilla de ADN , Egipto , Humanos , Masculino , Reacción en Cadena de la Polimerasa
4.
Carbohydr Polym ; 90(1): 658-66, 2012 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-24751090

RESUMEN

Nonwoven viscose fabric was treated with chitosan/polyvinyl alcohol (PVA) using pad-dry method, using different concentrations of chitosan and PVA. Increasing the amount of PVA leads to increasing of air permeability. Water permeability increased by increasing the amount of PVA to 2 ml (10% solution) then decreased by any increase of the quantity of PVA solution. Roughness increased with increasing the amount of 10% PVA solution. It is shown that roughness, water and air permeability increased with increasing the chitosan concentration. Antibacterial properties was increased with increasing PVA/or chitosan concentration. The chitosan/PVA treated nonwoven viscose fabric was immersed in a solution of Ag nanoparticles. The chitosan/PVA/Ag nanoparticles treated nonwoven fabrics were used as wound dressings on French white Bouscat rabbits, with age ranged from 1 to 2 years. A complete healing was achieved using wound dressing consists of nonwoven viscose fabric treated with chitosan/PVA/Ag nanoparticles after 21 days. The histopathological examination confirmed the complete re-epithelialization and averagely thick epidermis formation.

5.
Folia Morphol (Warsz) ; 67(1): 63-71, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18335416

RESUMEN

Entrapment neuropathy in the forearm is not uncommon. Surgical interference for nerve decompression should be preceded by accurate diagnosis of the exact cause and site of the nerve entrapment. The aim of the present study was to investigate the prevalence of accessory heads of the flexor pollicis longus and flexor digitorum profundus muscles (FPLah) and (FDPah) in Egyptians and their topographical relationship with both the median nerve and its anterior interosseous branch. A total of 42 upper limbs of embalmed cadavers, 36 from males and 6 from females, were examined to elucidate the prevalence of both the FPLah and the FDPah muscles, their origin, insertion, nerve supply and morphology. The distribution of these two muscles in the right and left male and female upper limbs and their relationship to the anterior interosseous and median nerves were recorded. The total lengths of both accessory muscles and the lengths of their fleshy bellies and tendons were also measured. The FPLah was found to be present more frequently (61.9%) than it was absent, whereas the FDPah was observed in only 14.24% of the specimens examined. The combination of the accessory muscles in the same forearm was noticed in 9.52% of cases. As regards side, the FPLah appeared in 77.7% of the right forearms and in 50% of the left, while the FDPah was found in only 25% of the left forearms. The accessory muscles showed no single morphology, as the FPLah appeared fusiform in 53.8%, slender in 30.8% and voluminous fusiform in 15.4%, while the FDPah was slender in 66.6% and triangular in 33.3% of specimens. The FPLah arose mainly from the under surface of flexor digitorum superficialis, while the FDPah took its origin from the under surface of flexor digitorum superficialis or from the medial epicondyle. The insertion of the FPLah was mainly into the upper third of the FPL tendon, while the FDPah tendon joined the tendons of the flexor digitorum profundus muscle to the index or middle and ring fingers. The FPLah was found between the median nerve anteriorly and the anterior interosseous nerve posteriorly. Both FPLah and FDPah took their nerve supply mainly from the anterior interosseous nerve and, less frequently, from the median nerve. The mean values of the total lengths of FPLah and FDPah were 74.66 mm and 208.33 mm, respectively. Cadaveric dissection in this study confirmed the prevalence of the FPLah and FDPah in Egyptians and demonstrated the relationship of the FPLah to the median nerve and its anterior interosseous branch. These findings may provide the surgeon with information for the differential diagnosis of the causes and sites of anterior interosseous nerve syndrome and entrapment neuropathy of the median nerve in the forearm


Asunto(s)
Antebrazo/anomalías , Músculo Esquelético/anomalías , Músculo Esquelético/inervación , Antropometría , Cadáver , Anomalías Congénitas/epidemiología , Disección , Egipto/epidemiología , Femenino , Dedos/anatomía & histología , Dedos/fisiología , Antebrazo/fisiología , Fuerza de la Mano/fisiología , Humanos , Masculino , Nervio Mediano/anatomía & histología , Nervio Mediano/fisiología , Movimiento/fisiología , Músculo Esquelético/fisiología , Prevalencia , Tendones/anomalías , Tendones/fisiología , Pulgar/anatomía & histología , Pulgar/fisiología , Muñeca/anomalías , Muñeca/fisiología
6.
Lancet ; 354(9179): 630-5, 1999 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-10466664

RESUMEN

BACKGROUND: Trachoma is the leading cause of preventable blindness. Programmes to prevent blindness due to trachoma are based on community-wide treatment with topical tetracycline. We assessed the potential of community-wide azithromycin treatment for trachoma control. METHODS: Pairs of villages in trachoma endemic areas of Egypt, The Gambia, and Tanzania were matched on trachoma rates in 1-10-year-old children. Villages were randomly assigned community-wide oral azithromycin treatment (three doses with intervals of 1 week) or treatment with 1% topical tetracycline (once daily for 6 weeks). Clinical examinations were done at baseline, 2-4.5 months, and 12-14 months after treatment. Chlamydia trachomatitis was identified by ligase chain reaction (LCR). Analyses were by intention to treat. Univariate comparisons and multivariate analyses were used to compare outcomes. FINDINGS: LCR positivity was correlated with clinical severity, but about 30% of Egyptian and Gambian villagers with no active disease were LCR positive. Village-wide LCR positivity ranged from 16.5% (Tanzania) to 43.6% (Egypt). Treatment compliance was over 90% except in the tetracycline treatment village in Egypt. Of the participants initially LCR positive, 866 (95%) of 924 who received at least one azithromycin dose and 482 (82%) of 587 who received 28 days or more topical tetracycline, were negative at follow-up. At 1 year, village-wide LCR positivity rates were substantially lower than at baseline with both treatments; the decreases were greater with azithromycin than with tetracycline (93% vs 77% in Egypt, 78 vs 66% in The Gambia, 64 vs 55% in Tanzania). Similarly, greater reduction in clinical activity occurred after azithromycin. In multivariate analyses, factors associated with being LCR positive at 1 year were: not receiving azithromycin; age under 10 years; and LCR positivity at baseline. INTERPRETATION: Community-wide treatment with oral azithromycin markedly reduces C. trachomatis infection and clinical trachoma in endemic areas and may be an important approach to control of trachoma.


Asunto(s)
Antibacterianos/uso terapéutico , Azitromicina/uso terapéutico , Tracoma/tratamiento farmacológico , Administración Oral , Niño , Preescolar , Esquema de Medicación , Egipto/epidemiología , Gambia/epidemiología , Humanos , Lactante , Tanzanía/epidemiología , Tetraciclina/uso terapéutico , Tracoma/diagnóstico , Tracoma/epidemiología
7.
Clin Infect Dis ; 24(3): 363-8, 1997 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9114186

RESUMEN

Trachoma, an infectious keratoconjunctivitis caused by Chlamydia trachomatis, is a leading cause of preventable blindness in developing countries. In this study we compared oral azithromycin with oxytetracycline/polymyxin eye ointment (once daily for 5 days every 4 weeks; total of six treatment cycles) for the treatment of active endemic trachoma in 168 rural Egyptian children. A suspension of azithromycin was administered to children as a dose of 20 mg/kg by one of three schedules: a single dose, one dose a week for 3 weeks, and one dose every 4 weeks for a total of six doses. The children's clinical status and chlamydial infection rates were evaluated for 1 year. The clinical cure rates were 35% 2 months after initial treatment, 16% at 8 months (during the annual autumn epidemic of purulent conjunctivitis), and 47% at 1 year. The pretreatment chlamydial infection rate of 33% (determined by direct immunofluorescence) decreased to 5% at 2 months and was 9% at 12 months. There were no significant clinical or laboratory differences among the four treatment groups. Thus, 1-6 doses of azithromycin were equivalent to 30 days of topical oxytetracycline/polymyxin ointment and may offer an effective alternative means of controlling endemic trachoma.


Asunto(s)
Antibacterianos/administración & dosificación , Azitromicina/administración & dosificación , Quimioterapia Combinada/administración & dosificación , Oxitetraciclina/administración & dosificación , Polimixinas/administración & dosificación , Tracoma/tratamiento farmacológico , Administración Oral , Administración Tópica , Niño , Preescolar , Chlamydia trachomatis/aislamiento & purificación , Conjuntiva/microbiología , Egipto , Femenino , Humanos , Masculino , Soluciones Oftálmicas , Proyectos Piloto
19.
Bull Ophthalmol Soc Egypt ; 68: 267-8, 1975.
Artículo en Inglés | MEDLINE | ID: mdl-1230213
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA